History of uterine leiomyoma and risk of endometrial cancer in black women
Previous studies have found an association between uterine leiomyomata (UL) and uterine malignancies. This relation has not been studied in black women, who are disproportionately affected by UL.
We investigated prospectively the association between self-reported physician-diagnosed UL and endometrial cancer in the Black Women’s Health Study. During 1995–2013, 47,267 participants with intact uteri completed biennial health questionnaires. Reports of endometrial cancer were confirmed by pathology data from medical records and cancer registries. Cox regression was used to derive incidence rate ratios (IRR) and 95 % confidence intervals (CI).
There were 300 incident endometrial cancer cases during 689,546 person-years of follow-up. In multivariable models, UL history was associated with a 42 % greater incidence of endometrial cancer compared with no such history (95 % CI 1.12–1.80). IRRs for cancer diagnosed 0–2, 3–9, and ≥10 years after UL diagnosis were 3.20 (95 % CI 2.06–4.98), 0.95 (95 % CI 0.60–1.52), and 1.35 (95 % CI 1.03–1.77), respectively. Stronger overall associations between UL history and endometrial cancer were observed for later stages at cancer diagnosis (IRR = 2.25, 95 % CI 1.09–4.63) and type II/III cancers (IRR = 3.13, 95 % CI 1.64–5.99).
In this large cohort of black women, a history of UL was positively associated with endometrial cancer, particularly type II/III tumors. The strongest association was observed for cancer diagnosed within 2 years of UL diagnosis, a finding that might be explained by greater surveillance of women with UL or misdiagnosis of cancer as UL. However, an association was also observed for cancer reported ≥10 years after UL diagnosis.
KeywordsAfrican-Americans Uterine leiomyoma Endometrial cancer Prospective studies
Black Women’s Health Study
Incidence rate ratio
The authors gratefully acknowledge the contributions of BWHS participants & staff. This research was supported by grants R03-CA169888 (PI: Wise), R01-CA058420 (PI: Rosenberg), and UMI-CA164974 (PI: Rosenberg) from the National Cancer Institute, National Institutes of Health. Data on endometrial cancer pathology were obtained from several state cancer registries (AZ, CA, CO, CT, DE, DC, FL, GA, IL, IN, KY, LA, MD, MA, MI, NJ, NY, NC, OK, PA, SC, TN, TX, VA) and results reported do not necessarily represent their views.
- 8.Whiteman MK, Kuklina E, Jamieson DJ, Hillis SD, Marchbanks PA (2010) Inpatient hospitalization for gynecologic disorders in the United States. Am J Obstet Gynecol 202(541):e1–e6Google Scholar
- 20.Viswanathan M, Hartmann K, McKoy N, Stuart G, Rankins N, Thieda P, Lux LJ, Lohr KN (2007) Management of uterine fibroids: an update of the evidence. Evid Rep Technol Assess (Full Rep) 154:1–122Google Scholar
- 31.Strauss J, Coutifaris C (1999) The endometrium and myometrium: regulation and dysfunction. In: Yen S, Jaffe JM, Barbieri RL (eds) Reproductive endocrinology. Saunders Press, Philadelphia, pp 218–256Google Scholar
- 40.Cox DR (1972) Regression models and life-tables. J Roy Stat Soc 34:187–220Google Scholar
- 53.Howlader N, Noone AM, Krapcho M et al (2014) SEER cancer statistics review, 1975–2012, National Cancer Institute. Bethesda, MD. http://seer.cancer.gov/csr/1975_2012/